Mori Hiroshi

Profile Information

Affiliation: Assistant Professor, Department of Nuclear Medicine, Kanazawa University Hospital

Degree: Doctor of Philosophy (Ph.D.)(Mar, 2022, Graduate School of Medical Science, Kanazawa University)
Doctor of Medicine (M.D.)(Mar, 2009, Shimane Medical University (Current Shimane University Faculty of Medicine))

researchmap Member ID: B000366935

External link: http://nucmed.w3.kanazawa-u.ac.jp/

Papers

Radiation exposure lymphocyte damage assessed by γ‑H2AX level using flow cytometry

Zhuoqing Chen, Hiroshi Wakabayashi, Rie Kuroda, Hiroshi Mori, Tomo Hiromasa, Daiki Kayano, Seigo Kinuya

Scientific Reports, 14(4339), Feb, 2024 Peer-reviewed
Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac 123I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT

Shintaro Saito, Kenichi Nakajima, Takayuki Shibutani, Hiroshi Wakabayashi, Hiroto Yoneyama, Takahiro Konishi, Hiroshi Mori, Aki Takata, Seigo Kinuya

Annals of Nuclear Cardiology, 9(1) 61-67, Sep, 2023 Peer-reviewed
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.

Norihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Aki Takata, Tomo Hiromasa, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Hiroshi Mori …

Endocrine journal, Dec 24, 2022 Peer-reviewed
125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia

Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Yoji Kitamura, Kazuma Ogawa, Seigo Kinuya, Junichi Taki

Journal of Nuclear Cardiology, Aug, 2022 Peer-reviewed
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma

Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe …

Annals of Nuclear Medicine, 36(3) 267-278, Mar, 2022 Peer-reviewed
Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction

Takafumi Yamase, Junichi Taki, Hiroshi Wakabayashi, Anri Inaki, Tomo Hiromasa, Hiroshi Mori, Norihito Akatani, Kazuma Ogawa, Kazuhiro Shiba, Seigo Kinuya

Annals of Nuclear Medicine, 36(3) 235-243, Mar, 2022 Peer-reviewed
Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy

Tomo Hiromasa, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Satoru Watanabe, Hiroshi Mori, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Shintaro Saito …

Annals of Nuclear Medicine, 36(1) 61-69, Jan, 2022 Peer-reviewed
Visualization of Dynamic Expression of Myocardial Sigma-1 Receptor After Myocardial Ischemia and Reperfusion Using Radioiodine-Labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) Imaging

Hiroshi Wakabayashi, Junichi Taki, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Kazuhiro Shiba, Kazuma Ogawa, Seigo Kinuya

CIRCULATION JOURNAL, 85(11) 2102-2108, Nov, 2021 Peer-reviewed
Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by 14C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT

Hiroshi Mori, Junichi Taki, Hiroshi Wakabayashi, Tomo Hiromasa, Anri Inaki, Kazuma Ogawa, Kazuhiro Shiba, Seigo Kinuya

Annals of Nuclear Medicine, 35(2) 253-259, Feb, 2021 Peer-reviewedLead author
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.

Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Yasuhiro Ikawa, Toshihiro Fujiki, Norihito Akatani, Takafumi Yamase, Satoru Watanabe …

Annals of nuclear medicine, 34(11) 840-846, Nov, 2020 Peer-reviewed
Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma

Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita …

Diagnostics, 10(9) 663-663, Sep 2, 2020 Peer-reviewed
The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis

Hiroshi MORI, Anri INAKI, Daiki KAYANO, Hiroshi WAKABAYASHI, Makoto HOSONO, Tatsuya HIGASHI, Noboru ORIUCHI, Koichiro ABE, Mayuki UCHIYAMA, Seigo KINUYA

Kaku Igaku, 57(1) 39-46, Jun, 2020 Peer-reviewedLead author
High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.

Daiki Kayano, Hiroshi Wakabayashi, Kenichi Nakajima, Rie Kuroda, Satoru Watanabe, Anri Inaki, Ayane Toratani, Norihito Akatani, Takafumi Yamase, Yuji Kunita …

Annals of nuclear medicine, 34(6) 397-406, Jun, 2020 Peer-reviewed
Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.

Takayuki Shibutani, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroshi Mori, Shinro Matsuo, Hiroto Yoneyama, Takahiro Konishi, Koichi Okuda, Masahisa Onoguchi, Seigo Kinuya

Annals of nuclear medicine, 33(2) 86-92, Feb, 2019 Peer-reviewed
Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma.

Hiroshi Wakabayashi, Tahahiro Konishi, Hiroto Yoneyama, Anri Inaki, Tomo Hiromasa, Takafumi Yamase, Norihito Akatani, Satoru Watanabe, Hiroshi Mori, Daiki Kayano …

Asia Oceania journal of nuclear medicine & biology, 7(2) 115-120, 2019 Peer-reviewed
Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.

Hiroshi Mori, Kenichi Nakajima, Suguru Kadomoto, Atsushi Mizokami, Hiroko Ikeda, Hiroshi Wakabayashi, Seigo Kinuya

Internal medicine (Tokyo, Japan), 57(21) 3123-3128, Nov 1, 2018 Peer-reviewedLead author

Presentations

Examination of optimum conditions for 99mTc brain perfusion SPECT using a new SZHRX collimator

T. Nishiyama, M. Onoguchi, T. Shibutani, A. H. Vija, F. Massanes, T. Shimizu, H. Yoneyama, T. Konishi, H. Mori, K. Nakajima

EANM 2023, Sep, 2023
Positive Protective Effects of Sigma-1 Receptor Stimulation with Fluvoxamine after Myocardial Ischemia and Reperfusion in Rat

X. Zhang, H. Wakabayashi, H. Mori, T. Hiromasa, Z. Chen, T. Kozaka, K. Ogawa, S. Kinuya, J. Taki

EANM 2023, Sep, 2023
Dynamic Expression of Myocardial Sigma-1 Receptor in Doxorubicin-Induced Cardiomyopathy using Radioiodine Labeled 2-[4-(2iodophenyl)piperidino]cyclopentanol (OI5V) Imaging

Z. Chen, H. Wakabayashi, H. Mori, T. Hiromasa, X. Zhang, T. Kozaka, K. Ogawa, S. Kinuya, J. Taki

EANM 2023, Sep, 2023
新技術を知っておこう！核医学治療・ルタテラ治療

森博史

JCRミッドサマーセミナー2023, Jul 16, 2023 Invited
ソマトスタチン受容体シンチグラフィが有用であった異所性ACTH産生気管支カルチノイドの1例

松村武史, 森博史, 若林大志, 後藤久典, 齋藤大輔, 池田博子, 絹谷清剛

第96回日本核医学会中部地方会, Jul 8, 2023
金沢大学附属病院におけるLu-177 DOTATATEを用いたPRRTの実際

森博史, 廣正智, 若林大志, 萱野大樹, 絹谷清剛

第35回日本内分泌外科学会総会, Jun 15, 2023
金沢大学附属病院におけるPRRTの実際と症例提示について

森博史, 廣正智, 若林大志, 稲木杏吏, 萱野大樹, 絹谷清剛

第82回日本医学放射線学会総会, Apr 13, 2023
Meet the Expert：神経内分泌腫瘍のPRRTの実際について

森博史, 廣正智, 若林大志, 稲木杏吏, 萱野大樹, 絹谷清剛

第32回臨床内分泌Update, Nov 11, 2022 Invited
Utility of whole-body MRI in each organ compared with I-123/131 mIBG images in patients with metastatic pheochromocytoma and paraganglioma

Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Tomo Hiromasa, Satoru Watanabe, Takafumi Yamase, Kotaro Yoshida, Toshifumi Gabata, Seigo Kinuya

WFNMB 2022, Sep, 2022
Myocardial ischemia upregulates Sigma-1 receptor expression by depending on the severity of ischemia

Taki J, Wakabayashi H, Mori H, Hiromasa T, Akatani N, Shiba K, Ogawa K, Kinuya S

EANM 2021, Oct, 2021
Comparisons of detectability between whole-body MRI and I-123/131 mIBG images in patients with metastatic pheochromocytoma and paraganglioma

Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Tomo Hiromasa, Satoru Watanabe, Takafumi Yamase, Kotaro Yoshida, Toshifumi Gabata, Seigo Kinuya

SNMMI 2021 Annual Meeting, Jun 11, 2021
Comparable diagnostic accuracy with whole-body MRI and I-123/I-131 mIBG images in patients with metastatic pheochromocytoma and paraganglioma

Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Tomo Hiromasa, Satoru Watanabe, Takafumi Yamase, Kotaro Yoshida, Toshifumi Gabata, Seigo Kinuya

Apr 15, 2021
前立腺癌骨転移病変に対する放射線外照射後のregional Bone Scan Indexの経時的変化と検討

森博史, 中嶋憲一, 若林大志, 高田亜希, 渡辺悟, 山瀬喬史, 赤谷憲一, 稲木杏吏, 萱野大樹, 溝上敦, 絹谷清剛

第60回日本核医学会学術総会, Nov 13, 2020
Correlative comparison of the effectiveness of colchicine treatment after severe myocardial ischemia and reperfusion using C-14-methionine autoradiography, Tc-MIBI gated SPECT, and dual-immunofluorescence staining

Hiroshi Mori, Junichi Taki, Hiroshi Wakabayashi, Tomo Hiromasa, Anri Inaki, Kazuma Ogawa, Kazuhiro Shiba, Seigo Kinuya

SNMMI 2020 Annual Meeting, Jul 11, 2020
Colchicine treatment after severe ischemia and reperfusion attenuates myocardial inflammatory response demonstrated by 14C-methionine imaging and subsequent ventricular remodeling

Hiroshi Mori, Junichi Taki, Hiroshi Wakabayashi, Tomo Hiromasa, Anri Inaki, Kazuma Ogawa, Kazuhiro Shiba, Seigo Kinuya

SNMMI 2019 Annual Meeting, Jun 25, 2019, Society of Nuclear Medicine And Molecular Imaging
I-131 MIBG治療後画像による高リスク神経芽腫患者の病変評価

森博史, 若林大志, 廣正智, 高田亜希, 渡辺悟, 山瀬喬史, 萱野大樹, 赤谷憲一, 稲木杏吏, 絹谷清剛

Nov, 2018
Effectiveness of I-123 MIBG SPECT Scoring with IQ SPECT System in Cardiac Sympathetic Nerve Function

Hiroshi Mori, Shinro Matsuo, Hiroshi Wakabayashi, Kenichi Nakajima, Seigo Kinuya

2018 Annual Congress of East Asia Nuclear Medicine Association, Nov, 2018
CT-Attenuation Correction of MIBG Scoring in Conventional and IQ system for Quantitative Analysis of Cardiac Sympathetic Nerve Function

Hiroshi Mori, Shinro Matsuo, Hiroshi Wakabayashi, Kenichi Nakajima, Seigo Kinuya

European Association of Nuclear Medicine (EANM) 31st Annual Congress, Oct, 2018
Curie score comparison of high-dose I-131 MIBG post-therapy images versus FDG-PET/CT images in high-risk neuroblastoma

Hiroshi Mori, Hiroshi Wakabayashi, Tomo Hiromasa, Aki Takata, Satoru Watanabe, Takafumi Yamase, Norihito Akatani, Anri Inaki, Daiki Kayano, Seigo Kinuya

The 12th Congress of The World Federation of Nuclear Medicine and Biology, Apr, 2018
The comparison of quantitative SPECT/CT scoring of I-123 MIBG cardiac scintigraphy and the heart-to-mediastinum ratio in IQ-SPECT system

Hiroshi Mori, Shinro Matsuo, Hiroshi Wakabayashi, Kenichi Nakajima, Seigo Kinuya

The 77th Annual Meeting of the Japan Radiological Society., Apr, 2018

Books and Other Publications

JCR50周年企画 JCR ミッドサマーセミナー2023厳選トピックス核医学治療・ルタテラ治療

森博史, 萱野大樹

臨床画像, Mar, 2024
新核医学テキスト

森博史 (Role: Contributor, 臨床診断11.腫瘍PET乳癌)

中外医学社, Nov, 2023 (ISBN: 9784498065307)
新核医学テキスト

森博史 (Role: Contributor, 臨床治療6.Lu-177DOTATATE)

中外医学社, Nov, 2023 (ISBN: 9784498065307)
褐色細胞腫・パラガングリオーマに対する核医学治療

國田優志, 森博史, 絹谷清剛

臨床泌尿器科, Sep, 2023
Refresher Course 核医学クイックレビュー(第3回) 最近話題の核医学治療

森博史, 若林大志, 廣正智, 稲木杏吏, 萱野大樹, 絹谷清剛

(株)Gakken, Mar, 2023 (ISBN: 9784055200059)
【内分泌腫瘍における核医学治療-現状と将来】ペプチド受容体放射性核種療法

森博史, 廣正智, 若林大志, 萱野大樹, 絹谷清剛

(一社)日本内分泌外科学会, Mar, 2023
【内分泌腫瘍における核医学治療-現状と将来】褐色細胞腫・パラガングリオーマ

廣正智, 張雪, 森博史, 若林大志, 萱野大樹, 絹谷清剛

(一社)日本内分泌外科学会, Mar, 2023
褐色細胞腫・パラガングリオーマに対するI-123MIBGシンチグラムとI-131MIBG治療について

森博史, 萱野大樹

JCRニュース, Sep, 2022
【褐色細胞腫update 2022】放射線治療のupdate

森博史, 若林大志, 萱野大樹, 絹谷清剛

(一社)日本内分泌外科学会, Jun, 2022

Research History

Apr, 2023 - Present

Assistant Professor, Hospital, Kanazawa University
Oct, 2021 - Mar, 2023

医員, 核医学診療科, 金沢大学附属病院
Apr, 2021 - Sep, 2021

医員, 放射線科, 金沢医科大学病院
Apr, 2017 - Mar, 2021

Medical Staff, Department of Nuclear Medicine, Kanazawa University Hospital

Education

Apr, 2017 - Mar, 2022

Doctoral Course, Graduate School of Medical Scienses, Kanazawa University Graduate School

Awards

Research Areas

Life sciences / Radiology / Nuclear Medicine

Research Interests

Research Projects

心筋梗塞後抑うつ状態におけるシグマ1受容体定量可視化による心脳連関の解明

科学研究費助成事業若手研究, 若手研究, 日本学術振興会, Apr, 2022 - Mar, 2026

森博史
原発性アルドステロン症における新治療戦略ー安全かつ高奏功な根本治療の開発

科学研究費助成事業基盤研究(B), 基盤研究(B), 日本学術振興会, Apr, 2022 - Mar, 2026

絹谷清剛, 森博史

Committee Memberships

Apr, 2023 - Mar, 2025

Nuclear medicine therapy team, Japan Board of Nuclear Medicine Technology (JBNMT)

Academic Activities

第66回日本甲状腺学会学術集会

Planning, management, etc.

Dec 7, 2023 - Dec 9, 2023
第23回日本核医学会春季大会

Planning, management, etc.

Apr, 2023 - Jun, 2023
第62回日本核医学会学術総会

Planning, management, etc.

Sep 9, 2022 - Sep 11, 2022
第13回世界核医学大会

Planning, management, etc.

Sep 7, 2022 - Sep 11, 2022

Social Activities

核医学看護のための放射線安全セミナー

Lecturer

公益社団法人日本アイソトープ協会, Mar 17, 2024
Pre-CC OSCE外部評価者

Logistic support

公益社団法人医療系大学間共用試験実施評価機構, 東京医科歯科大学医学部, Feb 18, 2024
令和6年度大学入学共通テスト主任監督者

Logistic support

独立行政法人大学入試センター, Jan 13, 2024 - Jan 14, 2024
Pre-CC OSCE内部評価者

Logistic support

公益社団法人医療系大学間共用試験実施評価機構, 金沢大学医薬保健学域医学類, Sep 9, 2023

Professional Memberships

Mar, 2011 - Present

JAPAN RADIOLOGICAL SOCIETY
Mar, 2014 - Present

JAPANESE SOCIETY FOR RADIATION ONCOLOGY
Jun, 2014 - Present

JAPANESE SOCIETY OF NUCLEAR MEDICINE
Jan, 2023 - Present

日本内分泌外科学会

Teaching Experience

核医学 (金沢大学)

Profile Information

Papers

Presentations

Books and Other Publications

Research History

Education

Awards

Research Areas

Research Interests

Research Projects

Committee Memberships

Academic Activities

Social Activities

Professional Memberships

Teaching Experience

Menu

Coauthors